CD34 and Kaposi's sarcoma: Despite variable transcriptomic expression (on average 1.40-fold upregulated), CD34 was included for lineage discrimination since it has been detected previously in KS lesions at the protein level and is a marker for vascular endothelial cells and hematopoietic stem cells [18,23].